Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
201.00    -1.60 (-0.79%)
Bid:
200.80
Ask:
201.40
Spread: 0.60 (0.299%)
Market Cap: £1.31b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

End of Stabilisation

24 Oct 2006 07:02

Ashmore Group PLC24 October 2006 These written materials are not for distribution (directly or indirectly) in orto the United States, Canada, Australia or Japan. They are not an offer ofsecurities for sale in or into the United States, Canada, Australia or Japan. The Shares of the Company are not being registered under the US Securities Actof 1933, as amended (the 'Securities Act') and may not be offered or sold in theUnited States unless registered under the Securities Act or pursuant to anexemption from such registration. No money, securities or other considerationis being solicited and, if sent in response to the information contained herein,will not be accepted. 24 October 2006 Ashmore Group plc ('Ashmore' or the 'Company') Announcement of Utilisation of Over-allotment Option: Ashmore Group plc In connection with the Placing in relation to the following ordinary shares: Ashmore Group plc ordinary shares of 0.01p eachISIN Code: GB00B132NW22 Ashmore announces that, in connection with the Placing of 177,266,000 ordinaryshares by Ashmore, UBS Limited, as stabilising manager, has given notice toutilise the Over-allotment Option in full in respect of 17,726,600 ordinaryshares in Ashmore. None of the £30.1 million gross proceeds arising from theutilisation of the Over-allotment Option will be received by Ashmore. Including the utilisation of the Over-allotment Option, the total size of thePlacing is 194,992,600 ordinary shares. Following the utilisation of theOver-allotment Option and as a consequence of the Over-allotment Arrangements,Mark Coombs will be beneficially interested in 303,324,200 Ashmore ordinaryshares and Jon Moulton will be beneficially interested in 30,511,700 Ashmoreordinary shares. The Placing Price of Ashmore ordinary shares of 0.01p each was set at 170p perordinary share on 12 October 2006. UBS Limited, as stabilising manager has also informed the Company that thestabilisation period which commenced at 8am on 12 October 2006 has now ended andthat it made no stabilisation trades. Further details in respect of the Over-allotment Option and the Over-allotmentArrangements are set out in Ashmore's Prospectus dated 12 October 2006. Defined terms used in this announcement have the same meaning as in theCompany's Prospectus dated 12 October 2006 unless the context requiresotherwise. This announcement may not be distributed, directly or indirectly, in or into theUnited States, Canada, Australia or Japan. This announcement is for information purposes only and does not constitute aninvitation or offer to underwrite, subscribe for or otherwise acquire or disposeof any securities of Ashmore Group plc in any jurisdiction. In addition, if and to the extent that this announcement is communicated in, orthe offer of the securities to which it relates is made in, any EEA Member Statethat has implemented Directive 2003/71/EC (together with any applicableimplementing measures in any Member State, the 'Prospectus Directive') beforethe publication of a prospectus in relation to the securities which has beenapproved by the competent authority in that Member State in accordance with theProspectus Directive (or which has been approved by a competent authority inanother Member State and notified to the competent authority in that MemberState in accordance with the Prospectus Directive), this announcement and thePlacing are only addressed to and directed at persons in that Member State whoare qualified investors within the meaning of the Prospectus Directive (or whoare other persons to whom the offer may lawfully be addressed) and must not beacted on or relied on by other persons in that Member State. The Placing and the distribution of this announcement and other information inconnection with the Placing in certain jurisdictions may be restricted by lawand persons into whose possession any document or other information referred toherein comes should inform themselves about and observe any such restriction.Any failure to comply with these restrictions may constitute a violation of thesecurities laws of any such jurisdiction. This announcement is not an offer of securities for sale into the United States.The securities have not been, and will not be, registered under the U.S.Securities Act of 1933 and may not be offered or sold in the United Statesabsent registration or an exemption from registration. There will be no publicoffer of securities in the United States. Stabilisation/FSA END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.